Cationic lipids

Abstract

The present invention provides a technique that enables introduction of active ingredients, in particular, nucleic acids, into cells with superior efficiency; and cationic lipids, etc., for use in the technique. The compound or a salt thereof according to the present invention is a compound represented by formula (I) or a salt thereof. In formula (I), n represents an integer of 2 to 5, R represents a linear C 1-5 alkyl group, a linear C 7-11 alkenyl group, or a linear C 11 alkadienyl group, and wavy lines each independently represent a cis-bond or a trans-bond.

1 . A compound represented by formula (I): 
       
         
           
           
               
               
           
         
       
       wherein
 n represents an integer of 2 to 5, 
 R represents a linear C 1-5  alkyl group, a linear C 7-11  alkenyl group, or a linear C 11  alkadienyl group, and 
 wavy lines each independently represent a cis-bond or a trans-bond, 
 
       or a salt thereof. 
     
     
         2 . 3-((4-(Dimethylamino)butanoyl)oxy)-2,2-bis(((9Z)-tetradec-9-enoyloxy)methyl)propyl (9Z)-tetradec-9-enoate or a salt thereof. 
     
     
         3 . 3-((5-(Dimethylamino)pentanoyl)oxy)-2,2-bis(((9Z)-tetradec-9-enoyloxy)methyl)propyl (9Z)-tetradec-9-enoate or a salt thereof. 
     
     
         4 . 3-((6-(Dimethylamino)hexanoyl)oxy)-2,2-bis(((9Z)-tetradec-9-enoyloxy)methyl)propyl (9Z)-tetradec-9-enoate or a salt thereof. 
     
     
         5 . A lipid particle comprising the compound or a salt thereof according to  claim 1 . 
     
     
         6 . A composition for nucleic acid introduction comprising a nucleic acid and the lipid particle according to  claim 5 . 
     
     
         7 . The composition according to  claim 6 , wherein the nucleic acid is an RNA. 
     
     
         8 . The composition according to  claim 7 , wherein the RNA is an mRNA or an siRNA.